68Ga-DOTA-Siglec-9

N/A

Report date: 2025/11/20 11:38:14
NME

Base Information

Drug Name68Ga-DOTA-Siglec-9
Drug Alias Name[68Ga]DOTA-Siglec-9
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAmine oxidase, copper containing modulators
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsScleroderma, SystemicInflammatory Bowel DiseasesColitis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesTurku University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTurku University Hospital
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicInflammatory Bowel DiseasesColitis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A